Chardonnet Laurent 4
4 · Prelude Therapeutics Inc · Filed May 25, 2023
Insider Transaction Report
Form 4
Chardonnet Laurent
Chief Financial Officer
Transactions
- Purchase
Common Stock
2023-05-23$5.50/sh+5,000$27,500→ 42,165 total
Footnotes (1)
- [F1]The reported total includes 1,292 shares of common stock the reporting person has acquired since the date of his last ownership report through the issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c).